To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery
26. April 2012 aktualisiert von: McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Safety and Efficacy Study of Acetaminophen 1000 mg and Acetaminophen 650 mg in Post Operative Dental Pain
The objective of this study is to evaluate the safety and efficacy of acetaminophen 650 mg and acetaminophen 1000 mg in dental surgery.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
This trial is to assess the relative efficacy of acetaminophen 1000 mg versus acetaminophen 650 mg over a six-hour period, in subjects experiencing at least moderate post-operative dental pain.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
540
Phase
- Phase 3
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Utah
-
Salt Lake City, Utah, Vereinigte Staaten, 84124
- Jean Brown Research
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
16 Jahre bis 50 Jahre (Kind, Erwachsene)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Must be at least 16 and less than 51 years of age
- Must weigh at least 100 lbs with a body mass index of at least 18 and less than 30
- Must have up to four of their back teeth (third-molars) pulled
Exclusion Criteria:
- Cannot be allergic to acetaminophen (Tylenol)
- Cannot be pregnant (or planning to be pregnant) or nursing a baby
- Cannot have any other medical conditions that the investigator determines might compromise your safety or the study results
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: ACE-1000
1000 mg Acetaminophen Caplet
|
Acetaminophen Caplet - single dose
Andere Namen:
|
|
Aktiver Komparator: ACE-650
650 mg Acetaminophen Caplet
|
Acetaminophen Caplet - single dose
Andere Namen:
|
|
Placebo-Komparator: ACE-0
0 mg Acetaminophen Caplet
|
0 mg Caplet - single dose
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Overall Analgesic Efficacy - Sum of Pain Intensity Difference and Pain Relief Scores Over Six Hours (SPRID6)
Zeitfenster: 6 Hours
|
Weighted Sum of Pain Intensity Difference and Pain Relief Scores Over Six Hours (SPRID6) - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief.
For SPRID6, the total possible minimum value is -300 (worst) and the total possible maximum value is 1200 (best).
The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
|
6 Hours
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Sum of Pain Intensity Difference Over Six Hours (SPID6)
Zeitfenster: 6 Hours
|
Weighted Sum of the Pain Intensity Difference from Baseline Over Six Hours (SPID6) - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain.
The total possible minimum value is -300 (worst) and the total possible maximum value is 600 (best).
The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
|
6 Hours
|
|
Sum of Pain Relief Scores Over Six Hours (TOTPAR6)
Zeitfenster: 6 Hours
|
Weighted Sum of the Pain Relief Scores Over Six Hours (TOTPAR6) - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief.
The total possible minimum value is 0 (worst) and the total possible maximum value is 600 (best).
The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
|
6 Hours
|
|
Pain Intensity Difference (PID) at 15 Minutes
Zeitfenster: 15 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
15 Minutes
|
|
Pain Intensity Difference (PID) at 30 Minutes
Zeitfenster: 30 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
30 Minutes
|
|
Pain Intensity Difference (PID) at 45 Minutes
Zeitfenster: 45 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
45 Minutes
|
|
Pain Intensity Difference (PID) at 60 Minutes
Zeitfenster: 60 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
60 Minutes
|
|
Pain Intensity Difference (PID) at 75 Minutes
Zeitfenster: 75 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time Point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
75 Minutes
|
|
Pain Intensity Difference (PID) at 90 Minutes
Zeitfenster: 90 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
90 Minutes
|
|
Pain Intensity Difference (PID) at 120 Minutes
Zeitfenster: 120 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
120 Minutes
|
|
Pain Intensity Difference (PID) at 180 Minutes
Zeitfenster: 180 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
180 Minutes
|
|
Pain Intensity Difference (PID) at 240 Minutes
Zeitfenster: 240 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
240 Minutes
|
|
Pain Intensity Difference (PID) at 300 Minutes
Zeitfenster: 300 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
300 Minutes
|
|
Pain Intensity Difference (PID) at 360 Minutes
Zeitfenster: 360 Minutes
|
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100.
The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
|
360 Minutes
|
|
Pain Relief (PAR) Scores at 15 Minutes
Zeitfenster: 15 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
15 Minutes
|
|
Pain Relief (PAR) Scores at 30 Minutes
Zeitfenster: 30 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
30 Minutes
|
|
Pain Relief (PAR) Scores at 45 Minutes
Zeitfenster: 45 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
45 Minutes
|
|
Pain Relief (PAR) Scores at 60 Minutes
Zeitfenster: 60 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
60 Minutes
|
|
Pain Relief (PAR) Scores at 75 Minutes
Zeitfenster: 75 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
75 Minutes
|
|
Pain Relief (PAR) Scores at 90 Minutes
Zeitfenster: 90 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
90 Minutes
|
|
Pain Relief (PAR) Scores at 120 Minutes
Zeitfenster: 120 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
120 Minutes
|
|
Pain Relief (PAR) Scores at 180 Minutes
Zeitfenster: 180 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
180 Minutes
|
|
Pain Relief (PAR) Scores at 240 Minutes
Zeitfenster: 240 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
240 Minutes
|
|
Pain Relief (PAR) Scores at 300 Minutes
Zeitfenster: 300 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
300 Minutes
|
|
Pain Relief (PAR) Scores at 360 Minutes
Zeitfenster: 360 Minutes
|
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
|
360 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 15 Minutes
Zeitfenster: 15 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
15 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 30 Minutes
Zeitfenster: 30 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
30 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 45 Minutes
Zeitfenster: 45 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
45 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 60 Minutes
Zeitfenster: 60 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
60 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 75 Minutes
Zeitfenster: 75 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
75 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 90 Minutes
Zeitfenster: 90 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
90 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 120 Minutes
Zeitfenster: 120 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
120 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 180 Minutes
Zeitfenster: 180 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
180 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 240 Minutes
Zeitfenster: 240 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
240 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 300 Minutes
Zeitfenster: 300 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
300 Minutes
|
|
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 360 Minutes
Zeitfenster: 360 Minutes
|
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
|
360 Minutes
|
|
Time to Meaningful Pain Relief
Zeitfenster: within 6 Hours
|
Minutes until meaningful pain relief was achieved.
A stopwatch was provided to the subject after ingestion of the study medication.
The subject was instructed to stop the stopwatch when the relief from the starting pain was meaningful to them.
|
within 6 Hours
|
|
Time to Confirmed Perceptible Pain Relief
Zeitfenster: within 6 Hours
|
Minutes until confirmed perceptible pain relief was achieved.
A stopwatch was provided to the subject after ingestion of the study medication.
The subject was instructed to stop the stopwatch when they first began to feel any pain relieving effect whatsoever of the drug, that was when they first felt any pain relief.
It did not necessarily mean they felt completely better, although they might have, but when they first felt any difference in the pain.
|
within 6 Hours
|
|
Duration of Analgesia - Time to Rescue
Zeitfenster: within 6 Hours
|
Minutes until rescue medication was given.
|
within 6 Hours
|
|
Rescue Rates Through Four Hours
Zeitfenster: through 4 Hours
|
Percentage of subjects using rescue medication.
|
through 4 Hours
|
|
Rescue Rates Through Six Hours
Zeitfenster: through 6 Hours
|
Percentage of subjects using rescue medication.
|
through 6 Hours
|
|
Percentage of Subjects With >50% of the Maximum Possible TOTPAR6 Score
Zeitfenster: 6 Hours
|
Percentage of Subjects with >50% of the Maximum Possible TOTPAR6 Score - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 600 so >50% is >300 out of 600
|
6 Hours
|
|
Patient Global Evaluation
Zeitfenster: 6 Hours
|
Patient Assessment of the Pain Medication - Number of Subjects rating the medication they received as a pain reliever on a score of 0-4, where 0=poor, 1=fair, 2=good, 3=very good, 4=excellent
|
6 Hours
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Ermittler
- Studienleiter: Daniel Qi, M.D., McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn
1. Juni 2010
Primärer Abschluss (Tatsächlich)
1. Januar 2011
Studienabschluss (Tatsächlich)
1. Januar 2011
Studienanmeldedaten
Zuerst eingereicht
30. April 2010
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
3. Mai 2010
Zuerst gepostet (Schätzen)
4. Mai 2010
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
28. Mai 2012
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
26. April 2012
Zuletzt verifiziert
1. April 2012
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- ACEPAI2001
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Schmerzen
-
Foundation IRCCS San Matteo HospitalAktiv, nicht rekrutierendGreater Trochanteric Pain Syndrome beider unteren ExtremitätenItalien
-
Gazi UniversityAbgeschlossenGesäß-Tendinitis | Greater Trochanteric Pain Syndrome beider unteren ExtremitätenTruthahn
-
Lawson Health Research InstituteNoch keine RekrutierungSchmerzen im unteren Rücken | Greater Trochanteric Pain Syndrome
-
C.R.Darnall Army Medical CenterUnbekanntGreater Trochanteric Pain SyndromeVereinigte Staaten
-
Guna S.p.aBeendetGreater Trochanteric Pain Syndrome | Pertrochantäre Fraktur | Gesäß-Tendinitis | GTPS - Greater Trochanteric Pain Syndrome | Sehnenerkrankung | GesäßmuskulaturItalien
-
Smith & Nephew, Inc.AbgeschlossenHüftschmerzen chronisch | Greater Trochanteric Pain SyndromeAustralien
-
NHS Greater Glasgow and ClydeNHS Research ScotlandRekrutierungGreater Trochanteric Pain SyndromeVereinigtes Königreich
-
Kutahya Health Sciences UniversityRekrutierungGreater Trochanteric Pain SyndromeTruthahn
-
Massachusetts General HospitalAbgeschlossenGreater Trochanteric Pain SyndromeVereinigte Staaten
-
Montefiore Medical CenterNoch keine RekrutierungGreater Trochanteric Pain SyndromeVereinigte Staaten